Please use this identifier to cite or link to this item:
Title: Pharmacotherapeutic approaches in the treatment of Alzheimer’s Disease
Authors: Scerri, Charles
Keywords: Alzheimer's disease -- Disease management
Methyl aspartate
Issue Date: 2006
Publisher: Malta College of Pharmacy Practice
Citation: Scerri, C. (2006). Pharmacotherapeutic approaches in the treatment of Alzheimer’s Disease. Journal of the Malta College of Pharmacy Practice, 11, 8-10.
Abstract: Alzheimer’s disease (AD) is the most common form of dementia and accounts for major cognitive impairment in the elderly. It is a progressive neurodegenerative disorder with distinct pathology. At present, the pharmacotherapy of AD involves the use of acetylcholinesterase inhibitors and the N-methyl-D-aspartate (NMDA) receptor antagonist memantine. The former imply neuroprotection hence slowing disease progression while the latter may block neuronal excitotoxicity.
Appears in Collections:JMCPP, Issue 11
JMCPP, Issue 11
Scholarly Works - FacM&SPat

Files in This Item:
File Description SizeFormat 
2006-11-2.pdfPharmacotherapeutic approaches in the treatment of Alzheimer’s Disease62.34 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.